Advocacy Update Apr. 8, 2025
IN THIS ISSUE / Apr. 8, 2025
AADA asks FDA to continue collaboration on AI-enabled medical devices guidance
Support the second-largest physician PAC and federal dermatology champions
Regulatory Affairs
AADA asks FDA to continue collaboration on AI-enabled medical devices guidance
On April 3, the AADA urged the FDA to continue strong collaboration (PDF) with the physician community, ensuring that those who will ultimately use AI-enabled medical devices have a meaningful role in their development, design, testing, and implementation.
In the letter, the AADA “backed the FDA’s continued efforts to enhance the functionality of software and models in AI-powered medical devices, improving AI-assisted decision-making by physicians and patient outcomes.”
The AADA also asked to continue “ongoing collaboration between the agency, patient advocates, and dermatologists, ensuring that both physicians and patients are actively involved in the development, design, testing, validation, and implementation of AI-enabled medical devices, and ensuring the effectiveness, safety, and broad applicability of these AI tools, ultimately improving their use in clinical practice.”
State Advocacy
New Jersey expands children’s access to sunscreen
New Jersey enacted legislation allowing children to possess and use sunscreen and sun-protective clothing in school without requiring documentation from a physician. The new New Jersey law will create a consistent state policy that ensures children have access to FDA-approved sunscreen at school for over-the-counter use — at no cost to the state. The AADA has supported this effort for several legislative sessions through the SUNucate Coalition (PDF).
The SUNucate Coalition, which includes the American Society for Dermatologic Surgery Association, the American College of Surgeons, and the American College of Mohs Surgery, stated that New Jersey is joining “28 other states and the District of Columbia in taking this necessary and overdue step to empower students to properly protect their skin and allow them to safely enjoy the outdoors without making their parents jump through bureaucratic hoops.”
AADA News
Support the second-largest physician PAC and federal dermatology champions
SkinPAC is running ahead of our record-breaking fundraising in 2024 and has raised $563,003 from 567 individuals in 2025 as of April 3. SkinPAC helps strengthen our relationships on Capitol Hill and reinforces our grassroots and lobbying efforts.
Through a non-partisan political action committee like SkinPAC, you can support candidates who understand and fight for dermatologists and dermatology patients. SkinPAC is a critical tool that ensures AADA has opportunities to educate legislators and candidates on how their policies affect practices and patients.
Contribute online at www.skinpac.org or by texting SkinPAC to 71777. Email skinpac@aad.org with any questions.
The political purpose of the American Academy of Dermatology Association Political Action Committee ("SkinPAC") is to solicit and receive contributions to be used to make political campaign expenditures to those candidates for elective office, and other federal political committees, who demonstrate understanding and interest in the view and goals of the American Academy of Dermatology Association.
Contributions to SkinPAC are not deductible for federal income tax purposes. Contributions to SkinPAC must be made from your funds and may not be reimbursed. SkinPAC cannot accept contributions from corporate accounts. Any recommended contribution amount is merely a suggestion. All AADA members have the right to contribute more or less or refuse to contribute without reprisal. Federal law prohibits us from accepting contributions from foreign nationals. Federal law requires us to use our best efforts to collect and report the name, physical address, occupation, and name of the employer whose contributions exceed $200 in a calendar year.
